Remdesivir is one of the novel coronavirus treatments that has shown some efficacy, but the drug is already in short supply. The Trump administration purchased nearly the entire remdesivir supply that Gilead Science >>
remdesivir News
Gilead has a plan to make remdesivir more effective against coronavirus
Experimental coronavirus drug remdesivir is effective in mild to moderate COVID-19 cases, according to recent research. Remdesivir can’t prevent complications or reduce mortality, but Gilead thinks that administering the therapy earlier to confirmed >>
Researchers want to combine two drugs that could give coronavirus a ‘one-two punch’
Coronavirus treatments have been hard to come by, but researchers are hopeful that combining the antiviral drug remdesivir with a powerful anti-inflammatory could be effective. Remdesivir stops the virus from multiplying, while an >>
Coronavirus drug remdesivir is going to be hard to find in the US
Earlier this month, the FDA approved the drug remdesivir to treat patients hospitalized with COVID-19. Shipments of remdesivir began going out last week, but only 607,000 of the 1,500,000 vials that drugmaker Gilead >>
Two promising coronavirus drugs just failed in clinical trials
Two studies focusing on the most promising coronavirus drugs just delivered bad news about the COVID-19 treatments. An observational hydroxychloroquine study from New York revealed the drug failed to show any promise on >>
This coronavirus drug shows promise treating severe COVID-19 cases
A promising coronavirus drug that’s been in testing around the world for months is showing promise at treating COVID-19 severe cases. Remdesivir is the medicine in question, an anti-viral originally created to treat >>
